The risk may be fewer with bromocriptine. agonists utilized for hyperprolactinemia have not shown an elevated risk of valvular heart problems, but the chance ought to be talked about with sufferers, and echocardiographic surveillance needs to be regarded, especially when doses > three mg every week are used. The risk might be considerably less with